
enVVeno Medical
Innovative bioprosthetic solutions for advanced venous disease treatment, featuring first-in-class surgical and transcatheter valves.
Market cap
$70.9m
Enterprise value
$33m
Share price
$3.99 NVNO
Authorizing premium user...
Innovative bioprosthetic solutions for advanced venous disease treatment, featuring first-in-class surgical and transcatheter valves.